Brokerages Set BKV Corporation (NYSE:BKV) Target Price at $28.13

BKV Corporation (NYSE:BKV) has received an average recommendation of “Buy” from the eight ratings firms that are covering the firm, MarketBeat Ratings reports. Eight analysts have rated the stock with a buy recommendation. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $28.13.

BKV has been the subject of a number of recent research reports. Barclays increased their price objective on shares of BKV from $28.00 to $29.00 and gave the company an “overweight” rating in a research note on Monday, May 12th. Evercore ISI increased their price objective on shares of BKV from $20.00 to $26.00 and gave the company an “outperform” rating in a research note on Friday, May 30th. Truist Financial dropped their price objective on shares of BKV from $31.00 to $30.00 and set a “buy” rating for the company in a research note on Monday, March 17th. Finally, KeyCorp dropped their target price on shares of BKV from $27.00 to $25.00 and set an “overweight” rating for the company in a research report on Tuesday, March 4th.

Insider Buying and Selling

In other BKV news, insider Lindsay B. Larrick sold 15,000 shares of the stock in a transaction dated Tuesday, March 25th. The shares were sold at an average price of $21.07, for a total transaction of $316,050.00. Following the sale, the insider now owns 245,528 shares of the company’s stock, valued at $5,173,274.96. This represents a 5.76% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Ethan Ngo sold 21,667 shares of BKV stock in a transaction that occurred on Thursday, April 3rd. The stock was sold at an average price of $20.09, for a total transaction of $435,290.03. Following the sale, the insider now owns 286,008 shares of the company’s stock, valued at approximately $5,745,900.72. This represents a 7.04% decrease in their position. The disclosure for this sale can be found here. Insiders sold 183,777 shares of company stock worth $3,818,699 in the last quarter. 4.11% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On BKV

Institutional investors have recently modified their holdings of the business. Geode Capital Management LLC acquired a new stake in shares of BKV during the 4th quarter worth approximately $7,728,000. Bank of New York Mellon Corp acquired a new stake in shares of BKV during the 4th quarter worth approximately $695,000. Driehaus Capital Management LLC bought a new position in BKV during the 4th quarter worth approximately $9,553,000. SG Americas Securities LLC bought a new position in BKV during the 4th quarter worth approximately $157,000. Finally, Corebridge Financial Inc. bought a new position in BKV during the 4th quarter worth approximately $170,000.

BKV Stock Performance

Shares of BKV stock opened at $22.51 on Tuesday. BKV has a 52-week low of $15.00 and a 52-week high of $26.78. The firm has a fifty day moving average of $19.53 and a 200-day moving average of $21.50.

BKV (NYSE:BKV) last announced its quarterly earnings data on Friday, May 9th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.15 by $0.26. The business had revenue of $216.13 million during the quarter, compared to analyst estimates of $223.20 million. Sell-side analysts expect that BKV will post -1.82 earnings per share for the current year.

BKV Company Profile

BKV Corporation engages in the acquisition, operation, and development of natural gas and NGL properties. It is also involved in the gathering, processing, and transportation of natural gas. The company was founded in 2015 and is based in Denver, Colorado with additional offices in Tunkhannock, Pennsylvania and Fort Worth, Texas.